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Abstract 
Introduction: It is known that periodontal ligament stem cells (PDLSCs) can
differentiate into cementoblast-like cells, adipocytes and collagen-forming cells.
However, whether PDLSCs are able to differentiate into Schwann cells and which
method is best for their neural induction remain unknown. We attempted to
determine whether PDLSCs possessed the potential for neural differentiation
in vitro.
Materials and methods: We isolated and multiplied PDLSCs from periodontal
ligaments obtained from the teeth (n = 24) of 8-month-old beagle dogs. Four
protocols with different chemicals and growth factors were adopted to induce
the PDLSCs to differentiate into Schwann cells. Immunochemistry, RT-PCR and
qRT-PCR were performed to investigate the in vitro neural differentiation
potential of PDLSCs. 
Results: We compared the 4 different protocols and showed that all 4 protocols
could successfully induce PDLSCs to express nestin, GFAP and S100, markers
for Schwann cells. Further, qRT-PCR revealed relative differences in the expression
levels of these 3 genes in differentiated PDLSCs obtained by different protocols. 
Conclusions: We conclude that PDLSCs have neural/glial differentiation potential
in vitro and that neural/glial differentiation can be induced in PDLSCs if suitable
protocols are followed. We also found that supplementing the growth medium
with suitable growth factors is more effective than applying chemicals alone.
While nerve growth factor is more effective than platelet-derived growth factor
for inducing neural/glial differentiation in PDLSCs, pre-induction of PDLSCs with
dimethyl sulphoxide yields better results than those obtained with all-trans-
retinoic acid.
Key words: periodontal ligament, stem cells, neural/glial differentiation, Schwann
cells.
Introduction
Seo et al. [1] isolated periodontal ligament stem cells (PDLSCs) for the
first time in 2004, and the stem-cell characteristics of PDLSCs have since
been verified repeatedly by different groups [2-5]. Kawanabe et al. reported
that about 3.9% of periodontal ligament cells (PDLCs) express early
mesenchymal stem-cell markers such as STRO-1 and CD146/MUC18 [4];
another authors reported that approximately 30% of PDLCs could form
single-cell colonies, and then 30% of these colonies express STRO-1 [5]. 
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In vitro, PDLSCs can differentiate into cementoblast-
like cells, adipocytes and collagen-forming cells, and
when transplanted into immunocompromised
rodents, PDLSCs can generate a cementum/PDL-
like structure [1, 3-5]. Considering the periodontal
tissue regeneration ability of PDLSCs, we reasoned
that it would be ideal to seed these cells around
a tooth implant to induce periodontal ligament
reconstruction. Schwann cells (SCs) are known to
play a pivotal role in the regeneration, development
and function maintenance of peripheral nerves [6-
8], but until now, whether PDLSCs could
differentiate into SCs and whether such
differentiated periodontal ligament stem cells
(dPDLSCs) could improve the sensation and
perception of tooth implants was unknown. 
Bone marrow stromal cells (BMSCs) can
differentiate into neural-like cells under certain
conditions [9-11]. Recently, adipose-derived stem
cells (ADSCs) have also been shown to undergo
neural differentiation in vitro [12-15]. Therefore, we
proposed that PDLSCs could also differentiate into
neural-like cells or SCs in vitro. To test this
hypothesis, we attempted to induce PDLSCs to
undergo neural differentiation by using 4 different
protocols: protocol A adopted chemicals only;
protocol B added some growth factors; protocol C
replaced platelet-derived growth factor with nerve
growth factor; and the only difference between
protocols C and D was that all-trans-retinoic acid
was used in protocol D instead of DMSO in C. We
then compared their neural/glial induction
efficiency. Our positive results show that
differentiated PDLSCs have a great potential to be
applied in nerve tissue engineering around the
tooth implant and hence may improve its sensation
and perception in the future.
Materials and methods
All animal experiments in this report were
approved by the Ethical Guideline Committee for
Animal Care, West China College of Medical
Sciences, Sichuan University.
Isolation, culture and identification of PDLSCs
Twenty-four teeth from 4 normal 8-month-old
beagle dogs were collected under aseptic conditions
and placed in phosphate-buffered saline (PBS)
solution supplemented with 1% (v/v) penicillin/
/streptomycin for 5 min. According to the report of
Seo et al. [1], the periodontal ligament was gently
separated from the surface of the tooth root and
then dissociated with 0.25% trypsin (Sigma, UK)
and 0.1% collagenase (Sigma, UK) for 90 min at
37°C. The solution was passed through a 75-µm
filter to remove undissociated tissue, neutralized
with alpha-Modified Eagle Medium (α-MEM;
Hyclone, USA) containing 20% (v/v) fetal bovine
serum (FBS) (Hyclone, USA) and centrifuged at 
1000 × g for 8 min. Then, the cell pellet was
resuspended in α-MEM containing 20% (v/v) FBS
with 1% (v/v) penicillin/streptomycin solution and
cultured in an incubator at 37°C with 5% carbon
dioxide. The culture medium was first changed 
7 days later and then changed regularly at 3-day
intervals. The cells were passaged with
trypsin/EDTA (Sigma, UK) when required. 
To isolate PDLSCs, we used single-colony
selection [1, 2]. Briefly, single-cell suspensions of
PDLCs (1-2 cells/200 µl) were seeded into 96-well
culture plates at a density of 1-2 cells/well. The
plates were then incubated at 37°C with 5% carbon
dioxide. The medium was changed every 3 days.
After 2 weeks, aggregates of more than 50 cells
were scored as colonies; these were digested,
pooled together and transferred to 6-well culture
plates for propagation. The morphology of these
PDLCs was observed under a phase-contrast
microscope. PDLSCs were identified by seeding cells
onto coverslips and immunostaining with antibodies
against STRO-1, cytokeratin, vimentin (1 : 100
dilution) (Santa Cruz, CA, USA) and CD146/MUC18
(1 : 100 dilution) (Zymed Laboratories, USA). The
coverslips were examined using an Olympus IX 70
inverted phase-contrast microscope.
The potential of PDLSCs to differentiate into
multiple phenotypes has been investigated, 
as previously described [1, 2, 14]. Briefly, to 
induce differentiation into the osteogenic
phenotype, the cultures were treated with 
100 µg/ml ascorbate, 0.1 µM dexamethasone and
10 mM β-glycerophosphate for 3 weeks. The cells
were then fixed with 4% (w/v) paraformaldehyde
for 30 min at room temperature and washed 
3 times with PBS. To stain any calcium deposits, the
cells were then incubated with 1% (w/v) alizarin red
solution. To induce differentiation into the
adipogenic phenotype, the cells were treated with
0.5 mM isobutyl-methylxanthine (IBMX), 1 µM
dexamethasone, 10 µM insulin and 200 µM
indomethacin for 3 weeks. The cells were then fixed
with 10% (v/v) formalin for 60 min and washed in
H2O. Lipid clusters in the cells were stained with oil
red O.
Protocols used to induce PDLSCs to
differentiate into SCs 
Undifferentiated PDLSCs (uPDLSCs), which were
at 3 or 4 passages, about 3 weeks after primary
culture and 2 weeks after single colony isolation,
were used as the control group. To induce
differentiation of the PDLSCs to the SC phenotype,
the growth medium was removed from sub-
confluent cultures and replaced with medium
supplemented with 1 mM β-mercaptoethanol
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(Sigma-Aldrich, UK) for 1 day. Then, 4 different
protocols were followed to induce differentiation of
the PDLSCs [15]. 
1. Protocol A: The cells were washed and cultured
in α-MEM without FBS supplemented with 2%
dimethyl sulphoxide (DMSO) for 5 h. 
2. Protocol B: As in protocol A, the cells were first
washed. The medium was replaced with
a differentiation medium, i.e. cell-growth medium
supplemented with 10 ng/ml platelet-derived
growth factor (PDGF) (PeproTech Ltd., UK), 
10 ng/mL basic fibroblast growth factor (bFGF)
(PeproTech Ltd., UK), 14 µM forskolin (Sigma,
USA) and 10 ng/ml brain-derived neurotrophic
factor (BDNF) (PeproTech Ltd., UK). The cells were
incubated for 2 weeks under these conditions,
and fresh medium was added approximately
every 3 days. 
3.  Protocol C: This protocol was the same as
Protocol B, except that 10 ng/ml nerve growth
factor (NGF) (PeproTech Ltd., UK) was used
instead of 10 ng/ml PDGF. 
4. Protocol D: The cells were washed and cultured
in fresh medium supplemented with 35 ng/ml
all-trans-retinoic acid (Sigma, USA). After 3 days,
the cells were washed, and the medium was
replaced with a differentiation medium, as
described in protocol C. The only difference
between the last two protocols was that DMSO
in protocol C was replaced by all-trans-retinoic
acid in protocol D.
Immunocytochemistry
According to former reports [1, 2, 14], uPDLSCs
and dPDLSCs were seeded on glass coverslips for 
1 day and fixed in 4% (w/v) paraformaldehyde in PBS
(pH = 7.5) for 30 min. They were then washed with
PBS, before treatment with 3% (v/v) H2O2 for 5 min.
The coverslips were incubated for 1 h with blocking
buffer, i.e. 5% normal goat serum (Sigma, UK) in
0.1% Triton X-100 in PBS and then with primary
antibodies, including STRO-1 (1 : 100), cytokeratin
(1 : 100), vimentin (1 : 100), CD146/MUC18 (1 : 100),
S100 (1 : 100) (Santa Cruz, USA), glial fibrillary acidic
protein (GFAP) (1 : 200) (Santa Cruz, USA) and nestin
(1 : 100) (Santa Cruz) at 4°C overnight. After
thorough washing, the coverslips were incubated
with biotinylated secondary antibodies and then
with horseradish peroxide-conjugated streptavidin.
The peroxidase reaction was developed using 3, 
3’-diaminobenzidine tetrahydrochloride (DAB) as
chromogen. The coverslips were counterstained with
haematoxylin and then examined under an
Olympus IX 70 inverted phase-contrast microscope
(Olympus, Japan). STRO-1 was incubated with
fluorescein isothiocyanate (FITC)-conjugated
secondary antibody (1 : 100) (Santa Cruz), and the
fluorescence signals were detected with an Olympus
IX 70 fluorescence microscope (Olympus, Japan).
RNA reverse transcriptase polymerase chain
reaction (RT-PCR) and quantitative real-time
PCR analysis 
Total RNA was extracted using the Trizol reagent
(Invitrogen, USA), according to the manufacturer’s
instructions. RT-PCR and quantitative real-time PCR
were performed as described before [2, 15]. Briefly,
the yield and quality of the RNA were assessed by
measuring the absorbance at 260 and 280 nm,
followed by electrophoresis on a 3% (w/v) agarose
gel. Total RNA (500 ng) was reverse-transcribed into
complementary DNA (cDNA) with a PrimeScriptTM
RT Reagent Kit (Perfect Real Time, Takara, Japan)
according to the manufacturer’s guidelines. Primers
of S100, GFAP, nestin and the internal calibrator
glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
(synthesized by Takara Biological Technology 
Co. Ltd., Dalian, China) and their related GenBank
accession numbers are listed in Table I. PCR reaction
solution (25 µl: 12.5 µl, 2 × SYBR Premix Ex TaqTM;
0.5 µl, 10 µmol/l forward primer; 0.5 µl, 10 µmol/l
reverse primer; 0.5 µl, 50 × ROX Reference Dye1, 
2 µl, cDNA; and 9 µl, dH2O) was amplified using an
Applied Biosystems 7300 Real-Time PCR System
(Applied Biosystems, USA). The thermocycle of 
the PCR reaction was as follows: After an initial
Primer Sequences (5’-3’) Product size [bp] GenBank accession no.
S-100 For: ctcgacgtgttccagcagta 155 XM548737
Rev: ctgtccagtgtctccatgacc
NESTIN For: gggaagaatgtggtcaggact 165 XM547531
Rev: catcagactccctatccctgtc
GFAP For: ctggatctggagaggaagattg 162 XM843285
Rev: ttctcttagggctgctgtgag
GAPDH For: gatgctggtgctgagtatgttg 111 NM001003142
Rev: agaaggagcagagatgatgacc
For. and Rev. indicate forward, reverse primer, respectively. All primers were purchased from Takara Biological Technology Co. Ltd, (Dalian,
China)
Table I. Primer sets for RT-PCR and real-time PCR and GenBank accession numbers
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denaturation at 95°C for 10 s, 45 cycles of de  -
naturation at 95°C for 5 s and annealing at 60°C 
for 31 s were performed. The PCR products were
analysed using agarose gel electrophoresis 
(BIO-RAD, USA). During the real-time PCR,
fluorescence signals were collected during
annealing. The cycle of threshold value (Ct) was
calculated for further statistical analysis. In order
to examine the efficiency of the real-time PCR,
standard curves were established using a serial
dilution of the sample RNA (500 ng; S100, GFAP,
nestin and GAPDH; 10 × serial dilution). The total
RNA of the uPDLSCs was used as the non-template
control, which was included in all experiments and
in the RT- PCR in order to evaluate DNA
contamination of the reagents used for the
amplification. None of the experiments resulted in
a positive signal from the non-template control.
Statistical analysis 
All data were expressed as mean ± SEM.
Statistical calculations were performed using SPSS
software (SPSS, Chicago, IL, USA). Inter-group
comparisons were made by a one-way analysis of
variance (ANOVA), and then Tukey’s honestly
significant difference (HSD) test was performed for
multiple inter-group comparisons. P values less than
0.05 were considered significant.
Results
Under the phase-contrast microscope, the PDLSCs
appeared mainly polygonal with a nucleus in the
centre. Immunocytochemical assessment of the cell-
surface markers on PDLSCs revealed that the cells
were positive for STRO-1, CD146/MUC18 and vimentin
but negative for cytokeratin (Figure 1). The results
indicated that the cultured PDLSCs showed some
characteristics of adult stem cells – they expressed 
2 early mesenchymal stem-cell markers, STRO-1 and
CD146/MUC18. Vimentin expression further indicated
that the cultured PDLSCs were mesenchymal stem
cells derived from the embryonic mesoderm. Lack of
cytokeratin expression excluded the possibility that
the cells were from the ectoderm. These results are
consistent with other reports [1, 5, 16]. 
To investigate the potential to differentiate into
multiple phenotypes of the cells isolated from the
periodontal ligament, the cells were treated with
A
CD
FG
E
A’ B
Figure 1. Immunocytochemical assessment of PDLSCs cell markers. A – stro-1; A’ – live cell picture corresponding to A;
B – CD146(+); C – vimentin (+); D – cytokeratin (–); E – PDLSCs showed little polygon morphology; F – alizarin red
staining showed some mineralized nodule formation in PDLSCs cultures; G – cultured PDLSCs formed Oil Red 
O-positive lipid clusters. Scale bar = 50 µm
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agents known to induce differentiation into 
the osteoblastic and adipogenic phenotypes.
Differentiation into the osteoblastic phenotype was
confirmed by the presence of calcium deposits, as
detected with alizarin red (Figure 1F), and
differentiation into the adipogenic phenotype by
the presence of oil red O-positive lipid clusters
(Figure 1G).
While the uPDLSCs were negative for the neural
progenitor-cell marker nestin and glial cell markers
S100 and GFAP, all the dPDLSCs were positive 
in different degrees for nestin, S100 and GFAP
(Figure 2). 
To confirm the immunocytochemistry results, 
RT-PCR was performed, and the result is shown in
Figure 3. All dPDLSCs from all 4 protocols were
Figure 2. All differentiated PDLSCs after induction with protocol A, B, B and D showed positive in different degrees for
S-100, Nestin and GFAP; but undifferentiated PDLSCs showed negative for S-100, Nestin and GFAP . Protocol A: A. S100
(+), B. Nestin (+), C. GFAP (+); Protocol B: D. S100 (+), E. Nestin (+), F. GFAP (+); Protocol C: G. S100 (+), H. Nestin (+), 
I. GFAP (+); Protocol D: J. S100 (+), K. Nestin (+), L. GFAP (+); PDLSCs: M. S100 (–), N. Nestin (–), O. GFAP (–). Scale bar = 50 µm
AB C
DE F
GH I
JK L
MNO
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positive for S100, nestin and GFAP, but the uPDLSCs
were negative for S100, nestin and GFAP .
Subsequently, we performed real-time PCR to
consolidate the findings. For S100 and GFAP,
statistical analyses showed no statistically
significant differences between protocols A and B,
or C and D, respectively (P > 0.05). However, the
results of protocols C and D showed statistically
significant differences as compared with those of
protocols A and B (P < 0.05). Gene expression of
S100 in protocols C and D was higher than that in
protocols A and B (Tables II and III). For nestin gene
expression, there were no statistically significant
differences between protocols A and B (P > 0.05),
but there were differences between protocols C and
D (P < 0.05). All the results of protocols C and D
were significantly higher than those of protocols
A and B (P < 0.05), and nestin gene expression was
the highest in protocol C, closely followed by
protocol D (Table IV, Figure 4).
Discussion
In 2000, Woodbury and colleagues first
demonstrated that BMSCs could be induced to
differentiate into the neural phenotype in vitro with
β-mercaptoethanol, DMSO and butylated
hydroxyanisole as the neuronal induction medium.
However, these expressions were not sustained for
more than 6 days [17]. Thereafter, several studies
Group N Subset for alpha = 0.05
1* 2*
A 3 0.8817
B 3 0.9638
Tukey HSD** C 3 4.6976
D 3 5.8230
Sig. 1.000 0.664
Table II. S100 gene expression relative quantity
difference analyses
Figure 3. In above figures, all the differentiated PDLSCs from protocols A, B, C and D showed positive strips for S100,
Nestin and GFAP, while the control groups (undifferentiated PDLSCs: C-S100, C-Nestin and C-GFAP) showed no
positive strips for S100, Nestin and GFAP . We used GAPDH as a reference for assessing PCR ef Ficiency
*Means for groups in homogeneous subsets are displayed
**Uses harmonic mean sample size = 3.000
For groups A, B, C and D, there are no statistical differences within
subset 1 or 2, but there are statistical differences between subsets 
1 and 2
Group N Subset for alpha = 0.05
1* 2*
B 3 0.0000
A 3 3.4654
Tukey HSD** D 3 9.1448
C 3 10.2916
Sig. 0.272 0.911
Table III. GFAP gene expression relative quantity
difference analyses
*Means for groups in homogeneous subsets are displayed
**Uses harmonic mean sample size = 3.000
For groups A, B, C and D, there are no statistical differences within
subset 1 or 2, but there are statistical differences between subsets 
1 and 2
200 bp
150 bp
100 bp
200 bp
150 bp
100 bp
200 bp
150 bp
100 bp
200 bp
150 bp
100 bp
A
B
C
D
Marker                S100               C-S100        Nestin           C-Nestin           GFAP            C-GFAP         GAPDH
Group N Subset for alpha = 0.05
1* 2* 3*
A 3 0.0000
B 3 0.6357
Tukey HSD** D 3 3.7274
C 3 5.9861
Sig. 0.286 1.000 1.000
Table IV. Nestin gene expression relative quantity
difference analyses
*Means for groups in homogeneous subsets are displayed
**Uses harmonic mean sample size = 3.000
For groups A, B, C and D, there are no statistical differences within
subset 1 or 2, but there are statistical differences between subsets 
1 and 2
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reported that stable neural differentiation of BMSCs
and ADSCs could be induced by treating the cells
with chemicals combined with some growth factors
such as PDGF, NGF, bFGF and BDNF [14, 15, 18-22].
Based on these studies, we adopted 4 protocols for
inducing the neural differentiation of PDLSCs: one
with chemicals alone and the 3 others involving
chemicals in conjunction with different growth
factors. All 4 protocols successfully induced the
PDLSCs to differentiate into SCs, suggesting that
PDLSCs, like BMSCs and ADSCs, have neural
differentiation potential. 
Comparing protocol A with B and C showed that
adding suitable growth factors is more effective
than chemicals alone for inducing the neural/glial
differentiation of PDLSCs. Further comparing
protocol B with C, we observed that the neural/glial
induction efficiency of protocol C was significantly
better. NGF is a potent nerve growth factor and
plays a crucial role in the development and
preservation of the sensory and sympathetic
nervous systems; PDGF is a potent mitogen for
connective tissue cells and is involved in biological
processes such as hyperplasia and embryonic
neuron development. Both factors can promote
neural differentiation of PDLSCs. However, with
regard to inducing PDLSCs to differentiate into SCs,
NGF appears to be more effective than PDGF. 
The only difference between protocol C and D
was the pre-induction agent: 2% DMSO for 5 h in
protocol C and 35 ng/ml all-trans-retinoic acids for
72 h in protocol D. All-trans-retinoic acid was used
as a cell-differentiation factor by Sanchez and
colleagues [18], and recently it was considered
a pre-induction agent, which was to be used prior
to the addition of cell growth factors [14]. Although
the mechanism of DMSO to induce neural
differentiation is still unknown, DMSO has been
shown to play an important role in the neural
differentiation of stem cells [16, 20]. In addition to
enhanced expression of the nestin gene, we also
observed that PDLSCs treated with protocols C and
D expressed relatively higher levels of the S100 and
GFAP genes, indicating that the neural/glial-
induction efficiencies of protocols C and D for
PDLSCs are comparable. Thus, considering the lower
price and faster action of DMSO, we strongly
recommend that DMSO be used as a pre-induction
agent for the neural/glial differentiation of PDLSCs.
We conclude that PDLSCs have neural/glial
differentiation potential in vitro and that neural/glial
differentiation can be induced in PDLSCs if suitable
protocols are followed. We also found that
supplementing the growth medium with suitable
growth factors is more effective than applying
chemicals alone. While NGF is more effective than
PDGF for inducing neural/glial differentiation in
PDLSCs, pre-induction of PDLSCs with DMSO yields
better results than those obtained with all-trans-
retinoic acid.
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